🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.23
-0.49 (-4.57%)
Nov 20, 2026, 4:00 PM EST - Market closed

4D Molecular Therapeutics Market Cap

4D Molecular Therapeutics has a market cap or net worth of $576.76 million as of November 20, 2026. It is the 12,749th most valuable company in the world and the 2,533rd biggest in the United States. Its market cap has decreased by 6.53% in one year.

Market Cap
576.76M
Enterprise Value
240.14M
1-Year Change
-6.53%
Global Rank
Country Rank
#2,533 United States
Category

Chart

Chart

Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $576.76M, a decrease of -0.62%. That is a compound annual growth rate of -0.11%.

History

DateMarket Cap% Change
Nov 20, 2026576.76M34.60%
Dec 31, 2025428.51M66.42%
Dec 31, 2024257.49M-70.27%
Dec 29, 2023866.19M20.40%
Dec 30, 2022719.43M2.03%
Dec 31, 2021705.13M-35.79%
Dec 31, 2020 Pro Pro
Dec 11, 2020 (IPO) Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Annexon591.37M
Immix Biopharma583.33M
Design Therapeutics577.61M
Cullinan Therapeutics577.15M
Entera Bio575.53M
DBV Technologies571.97M
Geron560.94M
Bicara Therapeutics560.31M
Market Cap Rankings